Data required for the evaluation of newborn screening programmes
- 13 November 2003
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 162 (1) , S57-S61
- https://doi.org/10.1007/s00431-003-1354-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.2001
- Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiencyThe Lancet, 2001
- Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babiesArchives of Disease in Childhood: Fetal & Neonatal, 2001
- Evaluating newborn screening programmes based on dried blood spots: future challenges.British Medical Bulletin, 1998
- Neonatal screening for inborn errors of metabolism: cost, yield and outcome.Health Technology Assessment, 1997
- Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.Archives of Disease in Childhood, 1994
- Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected childrenThe Journal of Pediatrics, 1994
- Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency.Archives of Disease in Childhood, 1993
- Sudden Infant Death Syndrome and Inherited Disorders of Fatty Acid β-OxidationNeonatology, 1990
- Parental rights, child welfare, and public health: the case of PKU screening.American Journal of Public Health, 1982